Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
N NERVOUS SYSTEM
N06 PSYCHOANALEPTICS
N06A ANTIDEPRESSANTS
N06AX Other antidepressants
N06AX21 Duloxetine
D01179 Duloxetine hydrochloride (JAN/USP) <JP/US>
USP drug classification [BR:br08302]
Antidepressants
SSRIs/SNRIs (Selective Serotonin Reuptake Inhibitors/Serotonin and Norepinephrine Reuptake Inhibitors)
Duloxetine
D01179 Duloxetine hydrochloride (JAN/USP)
Anxiolytics
SSRIs/SNRIs (Selective Serotonin Reuptake Inhibitors/Serotonin and Norepinephrine Reuptake Inhibitors)
Duloxetine
D01179 Duloxetine hydrochloride (JAN/USP)
Central Nervous System Agents
Fibromyalgia Agents
Duloxetine
D01179 Duloxetine hydrochloride (JAN/USP)
Therapeutic category of drugs in Japan [BR:br08301]
1 Agents affecting nervous system and sensory organs
11 Agents affecting central nervous system
117 Psychotropics
1179 Others
D01179 Duloxetine hydrochloride (JAN/USP)
119 Miscellaneous
1190 Miscellaneous
D01179 Duloxetine hydrochloride (JAN/USP)
Drug groups [BR:br08330]
Neuropsychiatric agent
DG01658 Serotonin and norepinephrine reuptake inhibitor (SNRI)
DG00962 Duloxetine
D01179 Duloxetine hydrochloride
Metabolizing enzyme substrate
DG01892 CYP1A2 substrate
DG00962 Duloxetine
D01179 Duloxetine hydrochloride
DG01644 CYP2D6 substrate
DG00962 Duloxetine
D01179 Duloxetine hydrochloride
Metabolizing enzyme inhibitor
DG01645 CYP2D6 inhibitor
DG00962 Duloxetine
D01179 Duloxetine hydrochloride
Target-based classification of drugs [BR:br08310]
Transporters
Solute carrier family
SLC6
SLC6A2 (NAT1)
D01179 Duloxetine hydrochloride (JAN/USP) <JP/US>
SLC6A4 (HTT)
D01179 Duloxetine hydrochloride (JAN/USP) <JP/US>
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D01179
New drug approvals in Europe [br08329.html]
European public assessment reports (EPAR) authorised medicine
D01179
New drug approvals in Japan [br08318.html]
Drugs with new active ingredients
D01179
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D01179
Drug metabolizing enzymes and transporters [br08309.html]
Drug metabolizing enzymes
D01179
Pharmacogenomic biomarkers [br08341.html]
Polymorphisms and mutations affecting drug response
D01179
Drug groups [BR:br08330]
Neuropsychiatric agent
DG01658 Serotonin and norepinephrine reuptake inhibitor (SNRI)
DG00962 Duloxetine
Metabolizing enzyme substrate
DG01892 CYP1A2 substrate
DG00962 Duloxetine
DG01644 CYP2D6 substrate
DG00962 Duloxetine
Metabolizing enzyme inhibitor
DG01645 CYP2D6 inhibitor
DG00962 Duloxetine